Neutral on Biogen Zacks.com Other interesting candidates in the MS pipeline daclizumab, which is being developed in collaboration with Abbott Labs (ABT), and PEGylated interferon. Biogen's pipeline also has candidates for other ailments like amyotrophic lateral sclerosis (ALS), ... |
